Company Filing History:
Years Active: 1999-2007
Title: Asim Dasgupta: Innovator in Hepatitis C Research
Introduction
Asim Dasgupta is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of virology, particularly in the study of hepatitis C virus (HCV). With a total of 4 patents, his work has paved the way for advancements in antiviral strategies and genetic analysis.
Latest Patents
Dasgupta's latest patents include a groundbreaking cell culture system for the synthesis of infectious hepatitis C virus. This invention relates to a cDNA-based culture system capable of synthesizing infectious HCV in cell culture and facilitating cell-to-cell spread of the virus. Additionally, it presents a method for measuring the level of HCV infection in hepatocyte cells. Another notable patent is a method to identify internal ribosome entry site (IRES) elements using a bicistronic expression system for reporter proteins. The IRES elements identified through this method are instrumental in discovering trans-acting translation factors and developing antiviral agents.
Career Highlights
Asim Dasgupta is affiliated with the University of California, where he continues to advance his research in virology. His innovative approaches have garnered attention in the scientific community, contributing to a deeper understanding of HCV and its mechanisms.
Collaborations
Dasgupta has collaborated with notable colleagues, including Saumitra Das and Peter Coward. These partnerships have enhanced the scope and impact of his research endeavors.
Conclusion
Asim Dasgupta's contributions to hepatitis C research exemplify the importance of innovation in the field of virology. His patents not only advance scientific knowledge but also hold promise for the development of effective antiviral strategies.